Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 6-7, 2010, Pages 426-434

  Strålin, Kristoffer ^a   Olcén, Per ^a   Törnqvist, Eva ^a   Holmberg, Hans ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; DOXYCYCLINE; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CHLAMYDOPHILA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRACTICE GUIDELINE; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; ADOLESCENT; CHI SQUARE DISTRIBUTION; COMMUNITY-ACQUIRED INFECTIONS; GRAM-NEGATIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, BACTERIAL; SEVERITY OF ILLNESS INDEX; SWEDEN; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, BACTERIAL; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; SWEDEN;

EID: 77953255380     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365540903552353     Document Type: Article

References (34)

1. Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Karkola K, Korppi M, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993;137:977-988
2. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996;275:134-141
3. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001;56(Suppl 4):1-64.
4. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-72.
5. Woodhead M, Blasi F, Ewig S, Huchon G, Leven M, Örtqvist Å, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005;26:1138-1180
6. Hedlund J, Strålin K, Örtqvist Å, Holmberg H; the Community- Acquired Pneumonia Working Group of the Swedish Society of Infectious Diseases. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults. Scand J Infect Dis 2005;37:791-805.
7. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-250
8. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defi ning community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-382
9. Man SY, Lee N, Ip M, Antonio GE, Chau SS, Mak P, et al. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 2007;62:348-353
10. Capelastegui A, Espana PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006;27:151-157 (Pubitemid 43092679)
11. Ewig S, Welte T. CRB-65 for the assessment of pneumonia severity: who could ask for more? Thorax 2008;63:665-666
12. Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, et al. New perspectives on community-acquired pneumonia in 388,406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009;64:1062-1069
13. Strålin K, Goscinski G, Hedlund J, Lidman C, Spindler C, Örtqvist Å, et al. Management of adult patients with community- acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association. Läkartidningen 2008;105:2582-2587
14. Berntsson E, Blomberg J, Lagergård T, Trollfors B. Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol 1985;4:268-272
15. Holmberg H. Aetiology of community-acquired pneumonia in hospital treated patients. Scand J Infect Dis 1987;19:491-501.
16. Örtqvist Å, Hedlund J, Grillner L, Jalonen E, Kallings I, Leinonen M, et al. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J 1990;3:1105-1113
17. Burman LA, Trollfors B, Andersson B, Henrichsen J, Juto P, Kallings I, et al. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis 1991;163:1087-1093
18. Strålin K, Törnqvist E, Kaltoft MS, Olcén P, Holmberg H. Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples. J Clin Microbiol 2006;44:643-645
19. Strålin K, Kaltoft MS, Konradsen HB, Olcén P, Holmberg H. Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia. J Clin Microbiol 2004;42:3620-3625
20. Strålin K. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia. Int J Antimicrob Agents 2008;31:3-11.
21. Spindler C, Örtqvist Å. Prognostic score systems and community- acquired bacteraemic pneumococcal pneumonia. Eur Respir J 2006;28:816-823
22. Strålin K, Bäckman A, Holmberg H, Fredlund H, Olcén P. Design of a multiplex PCR for Streptococcus pneumoniae, Haemophilus infl uenzae, Mycoplasma pneumoniae and Chlamydophila pneumoniae to be used on sputum samples. APMIS 2005;113:99-111.
23. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J Suppl 2002;36:20s-7s.
24. Gunnarsson RK, Holm SE, Söderström M. The prevalence of potential pathogenic bacteria in nasopharyngeal samples from healthy children and adults. Scand J Prim Health Care 1998;16:13-17
25. Scott JA, Hall AJ. The value and complications of p ercutaneous transthoracic lung aspiration for the etiologic diagnosis of community-acquired pneumonia. Chest 1999;116:1716-1732
26. Ostergaard L, Andersen PL. Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology. Chest 1993;104:1400-1407
27. File TM Jr, Monte SV, Schentag JJ, Paladino JA, Klugman KP, Lavin B, et al. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic. Int J Antimicrob Agents 2009;33:58-64.
28. Torres A, Dorca J, Zalacain R, Bello S, El-Ebiary M, Molinos L, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med 1996;154:1456-1461
29. Shefet D, Robenshtok E, Paul M, Leibovici L. Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 2005;165:1992-2000. (Pubitemid 41362622)
30. Mills GD, Oehley MR, Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community-acquired pneumonia: meta-analysis. BMJ 2005;330:456.
31. Johnsson D, Mölling P, Strålin K, Söderquist B. Detection of Panton-Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects. Clin Microbiol Infect 2004;10:884-889
32. Strålin K, Söderquist B. Staphylococcus aureus in community- acquired pneumonia. Chest 2006;130:623.
33. Schwarzmann SW, Adler JL, Sullivan RJ Jr, Marine WM. Bacterial pneumonia during the Hong Kong infl uenza epidemic of 1968-1969. Arch Intern Med 1971;127: 1037-1041
34. Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-2004 infl uenza season. Emerg Infect Dis 2006;12:894-899